Please login to the form below

Not currently logged in
Email:
Password:

Vizamyl

This page shows the latest Vizamyl news and features for those working in and with pharma, biotech and healthcare.

EMA unveils draft guidelines for Alzheimer’s disease research

EMA unveils draft guidelines for Alzheimer’s disease research

Although the last few years have seen a number of Alzeimer's diagnostics approved, among them GE Healthcare Vizamyl (flutemetamol) and Piramal's Neuraceq (florbetaben F18), research progress for a treatment

Latest news

  • Biosimilar Lantus leads CHMP opinions Biosimilar Lantus leads CHMP opinions

    event. In addition GE Healthcare received a positive opinion for Vizamyl (flutemetamol) as a diagnostic for Alzheimer's disease. ... Vizamyl is a biomarker that can detect amyloid-beta neuritic plaques, where are formations in the brain associated with

  • CHMP backs Piramal's Alzheimer's imaging agent CHMP backs Piramal's Alzheimer's imaging agent

    18F) and GE Healthcare's Vizamyl (flutemetamol F18) on the market.

  • FDA approves Alzheimer's diagnostic drug FDA approves Alzheimer's diagnostic drug

    Vizamyl works by attaching to a peptide called beta amyloid in the brain, high levels of which have been associated with the development of Alzheimer's. ... A PET scan can then detect the presence of Vizamyl, allowing physicians to evaluate for the

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Alzheimers
Detecting Alzheimer’s ahead of a cure
A focus on promising new research...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...

Infographics